Deck 21: Parenteral Nutrition Support

Full screen (f)
exit full mode
Question
Traditionally, central catheters enter the circulation at the ____ vein and are threaded into the superior vena cava with the tip of the catheter lying close to the heart.

A) brachial
B) right subclavian
C) basilic
D) cephalic
Use Space or
up arrow
down arrow
to flip the card.
Question
Delivery of nutrient solutions directly into the vein is called ____.

A) standard nutrition
B) enteral nutrition
C) parenteral nutrition
D) tube feeding
Question
Redness, swelling, and tenderness at the infusion site of a vein is described as ____.

A) hematoma
B) phlebitis
C) infiltration
D) nerve damage
Question
A 21-year-old athlete who has a nonfunctional gastrointestinal tract is scheduled for major gastric surgery in 3 weeks. His energy and nutrient needs are higher than those of the average person his age, but his fluid intake is restricted. What would be the preferred method of feeding for this patient in order to keep him well nourished until surgery?

A) clear liquids
B) peripheral parenteral nutrition
C) total parenteral nutrition
D) mechanically soft diet
Question
The large-diameter central veins are located near the ____.

A) extremities
B) heart
C) liver
D) lungs
Question
Dextrose concentrations of ____ percent or lower can be used for peripheral parenteral nutrition solutions.

A) 10
B) 30
C) 50
D) 70
Question
What is an advantage of total parenteral nutrition?

A) Nutrient concentrations do not need to be limited.
B) It accesses only peripheral veins.
C) Patients who require only brief support (7 to 10 days) can use it.
D) It is less invasive.
Question
The small-diameter veins that are used for peripheral parenteral nutrition carry blood from the ___________.

A) heart
B) limbs
C) kidneys
D) brain
Question
Which statement regarding peripheral insertion of central catheters is false?

A) It is lower in cost
B) It is less invasive
C) It enters the circulation at the basilica vein
D) It enters the circulation at the right subclavian vein
Question
The protein in a total parenteral nutrition solution is primarily in the form of ____.

A) amino acids
B) protein hydrolysate
C) short-chain fatty acids
D) intact protein
Question
Peripheral parenteral nutrition is most often used in patients who require nutrition support for less than ____.

A) 2 weeks
B) 6 weeks
C) 3 months
D) 6 months
Question
Osmolality refers to milliosmoles of ions and molecules per _____

A) liter of solution (mOsm/L)
B) kilogram of solvent (mOsm/kg)
C) kilogram of solution (mOsm/kg)
D) liter of solvent (mOsm/L)
Question
Osmolarity refers to milliosmoles of ions and molecules per ____.

A) liter of solution (mOsm/L)
B) kilogram of solvent (mOsm/kg)
C) kilogram of solution (mOsm/kg)
D) liter of solvent (mOsm/L)
Question
Parenteral nutrition would most likely be contraindicated in which condition?

A) paralytic ileus
B) GI bleeding
C) severe hyperglycemia
D) intractable vomiting
Question
The use of peripheral parenteral nutrition is not recommended in a patient with ____.

A) a partially functioning GI tract
B) low pain tolerance
C) weak peripheral veins
D) a swallowing disorder
Question
Which form of glucose is typically used in parenteral solutions?

A) dextrose
B) fructose
C) lactose
D) galactose
Question
To prevent phlebitis, the osmolarity of parenteral solutions used for peripheral parenteral nutrition is generally kept below ____ milliosmoles per liter.

A) 300
B) 600
C) 900
D) 1200
Question
How much energy does dextrose provide?

A) 3.4 kcal/g
B) 4.0 kcal/g
C) 4.4 kcal/g
D) 5.0 kcal/g
Question
The movement of water across biological membranes is known as ____.

A) osmosis
B) peripheral transport
C) diffusion
D) absorption
Question
Osmolality is usually derived by using ____.

A) equations that account for the nutrients and electrolytes
B) the weights of the nutrients and solution
C) an instrument called an osmometer
D) an instrument called a spectrometer
Question
To prevent bacterial contamination and maintain stability, parenteral solutions are ____.

A) warmed to room temperature prior to infusion
B) exposed to light
C) pasteurized
D) compounded in the pharmacy under aseptic conditions
Question
How many kcalories are provided by 3 L of a 5% dextrose solution?

A) 150
B) 510
C) 600
D) 660
Question
The approximate osmolarity of a 1-L solution that contains 35 g of amino acids, 200 g of dextrose, 20 g of lipids from a 20% fat emulsion, and 150 mEq and mmol of electrolytes would be __________ mOsm/L.

A) 1039.4
B) 1339.2
C) 1514.2
D) 1729.4
Question
How many grams of amino acids would be provided to a client receiving 2000 mL of a 5% amino acid solution?

A) 50
B) 100
C) 200
D) 400
Question
Why are few medications added to parenteral solutions?

A) to avoid potential drug-nutrient interactions
B) because too many can destabilize the dextrose
C) because they are unnecessary if the solution is properly balanced
D) because it is not possible to do so
Question
Approximately how many liters of fluids will be required by a stable adult patient weighing 81 kg?

A) 1.4 to 2.2 L
B) 2.4 to 3.2 L
C) 3.2 to 4.0 L
D) 4.0 to 4.4 L
Question
The administration of a second solution using a separate port is called a ____.

A) Y-connector
B) piggyback
C) double-lumen tube
D) distal port
Question
Caution should be taken when administering parenteral lipids to people with which condition?

A) hypertriglyceridemia
B) hyperglycemia
C) diabetes
D) kidney failure
Question
Which vitamin is omitted from parenteral solutions prescribed for patients on warfarin therapy?

A) C
B) D
C) E
D) K
Question
Which macronutrient is usually the main source of energy in parenteral nutrition?

A) carbohydrate
B) protein
C) fat
D) amino acids
Question
The energy content of 2 L of a parenteral solution that contains 22% dextrose and 15% amino acids supplemented with 300 mL of a 10% lipid emulsion is _________ kcalories

A) 1696
B) 2696
C) 3696
D) 4696
Question
Daily fluid needs range from ____ mL per kilogram of body weight in most stable patients.

A) 5 to 15
B) 15 to 25
C) 30 to 40
D) 35 to 45
Question
A physician writes an order for a patient to receive lipid emulsions via total parenteral nutrition twice a week. The purpose of this order to supply lipids is mainly to ____.

A) provide essential fatty acids
B) provide nonessential amino acids
C) provide essential minerals
D) suppress the immune response
Question
Although the administration of 3-in-1 solutions is simpler because only one infusion pump is required, what can occur when lipid emulsions have been added?

A) The solution is too dense to use in a central vein.
B) The solution causes platelet aggregation.
C) The solution often becomes contaminated.
D) The solution can form large lipid droplets.
Question
Cyclic parenteral nutrition is administered over ____ hours per day.

A) 3 to 6
B) 6 to 8
C) 8 to 14
D) 12 to 18
Question
Which trace mineral is typically excluded from parenteral solutions because it alters the stability of the other ingredients in the solution?

A) zinc
B) copper
C) iron
D) selenium
Question
Which condition describes a metabolic complication of parenteral nutrition?

A) hypoglycemia
B) phlebitis
C) air embolism
D) sepsis
Question
A 3-in-1 solution that contains amino acids, lipids, and dextrose is also called a ____.

A) hydrolyzed solution
B) total nutrient admixture
C) elemental suspension
D) isotonic solution
Question
Which type of oil most commonly makes up the triglycerides in lipid emulsions?

A) corn oil
B) sunflower oil
C) soybean oil
D) coconut oil
Question
One major benefit of cyclic infusion of total parenteral nutrition is ____.

A) maintenance of high insulin levels
B) increase in fat stores
C) more freedom of movement during the day
D) achievement of a negative nitrogen balance
Question
Which type of parenteral nutrition provided at night allows patients to participate in routine activities during the day?

A) continuous
B) cyclic
C) peripheral
D) piggyback
Question
Before parenteral nutrition is discontinued, oral intake, tube feeding, or a combination of both should provide at least _____ percent of the estimated energy needs.

A) 40 to 50
B) 55 to 60
C) 60 to 75
D) 90 to 95
Question
Which statement is true of Terri's Law?

A) It allows hospitals to withdraw life-sustaining treatment against the wishes of the family.
B) It allowed the governor to order hospitals to withdraw life-sustaining treatment against the wishes of the family, but was found unconstitutional.
C) It allows hospitals to continue life-sustaining treatment against the wishes of the family.
D) It allowed the governor to intervene and act against a family's wishes in order to continue life-sustaining treatment, but was found unconstitutional.
Question
A patient should be fully informed of a treatment's benefits and risks in a fair and honest manner. If the patient agrees to the proposed treatment, it is referred to as ____.

A) autonomy
B) informed consent
C) beneficence
D) distributive justice
Question
When providers consider whether provision of health care for one patient would unfairly limit the care of other patients, ____ is being considered.

A) autonomy
B) informed consent
C) beneficence
D) distributive justice
Question
The enteral formula used for home nutrition is most often influenced by cost and ____.

A) taste
B) availability
C) efficiency of administration
D) appearance
Question
A 12-year-old patient is being weaned off of total parenteral nutrition. In addition to total parenteral nutrition, he is on a soft diet. The patient is 5 ft 2 in. tall and weighs 110 lb. His energy needs are estimated to be approximately 2100 kcal/day. His kcalorie count reveals he is consuming 1700 kcal/day. Which intervention is appropriate at this time?

A) Discontinue TPN.
B) Double his oral feedings.
C) Consider enteral feedings.
D) Increase TPN to provide an additional 1100 kcal.
Question
Shawna is on home total parenteral nutrition and is having trouble adjusting to the changes in her life. Which organization does the text recommend as a good source of support and information for her?

A) Oley Foundation
B) P-CAN
C) Livestrong
D) ACS
Question
One of the greatest concerns of patients who use home nutrition support is the ____.

A) inability to consume meals with friends
B) appearance of the tube
C) risks of the tube becoming clogged
D) inability to choose the type and amount of formula delivered
Question
Liver enzymes should be monitored ____ during parenteral support.

A) hourly
B) daily
C) weekly
D) every 2 weeks
Question
How often should the fluid intake and output of a patient on total parenteral nutrition be checked?

A) before starting
B) every 4 to 8 hours
C) daily
D) once a week
Question
Refeeding syndrome is characterized by fluid and electrolyte imbalances and ____.

A) systemic infection
B) hypothyroidism
C) severe weight loss
D) hyperglycemia
Question
Which condition describes a catheter-related complication of parenteral nutrition?

A) refeeding syndrome
B) gallbladder disease
C) air embolism
D) nutrient deficiencies
Question
What best describes the role of the nurse on the nutrition support team?

A) diagnosing nutrition problems
B) recommending the appropriate diet
C) performing direct patient care
D) recommending appropriate drug therapy
Question
The health care team has just ordered total parenteral nutrition for Mr. Calabria. He is a 58-year-old man who is suffering from intractable diarrhea. Before Mr. Calabria starts TPN, what procedure should be performed?

A) X-ray to confirm catheter placement
B) body mass index assessment
C) calcium balance
D) hand grip strength
Question
A female patient who is on long-term parenteral nutrition is at risk for ____.

A) type 1 diabetes
B) osteoporosis
C) liver cancer
D) heart disease
Question
In which situation would home total parenteral nutrition be an appropriate means for maintaining adequate nutrition status?

A) an individual with dysphagia
B) an individual with chronic intestinal obstruction
C) an individual with head and neck cancer
D) an individual with neurological impairment affecting the esophagus
Question
The potential good that can come from a proposed treatment is referred to as ____.

A) autonomy
B) informed consent
C) beneficence
D) distributive justice
Question
When refrigerated, ready-made parenteral solutions may be stable for ____.

A) 1 week
B) 10 days
C) 2 weeks
D) 3 weeks
Question
A patient on total parenteral nutrition for longer than a few ____ is at risk for "sludge" buildup in the gallbladder and gallstone formation.

A) hours
B) days
C) weeks
D) months
Question
Match between columns
kcalories in 360 mL of a 20% lipid emulsion
396
kcalories in 360 mL of a 20% lipid emulsion
578
kcalories in 360 mL of a 20% lipid emulsion
total parenteral nutrition
kcalories in 360 mL of a 20% lipid emulsion
piggyback
kcalories in 360 mL of a 20% lipid emulsion
continuous parenteral nutrition
kcalories in 360 mL of a 20% lipid emulsion
osmolality
kcalories in 360 mL of a 20% lipid emulsion
peripheral veins
kcalories in 360 mL of a 20% lipid emulsion
central veins
kcalories in 360 mL of a 20% lipid emulsion
total nutrient admixture
kcalories in 360 mL of a 20% lipid emulsion
720
kcalories in 360 mL of a 20% lipid emulsion
cyclic parenteral nutrition
kcalories in 360 mL of a 20% lipid emulsion
peripheral parenteral nutrition
kcalories in 360 mL of a 20% lipid emulsion
2-in-1 solution
kcalories in 360 mL of a 20% lipid emulsion
osmolarity
kcalories in 360 mL of a 20% lipid emulsion
refeeding syndrome
kcalories in 360 mL of a 20% lipid emulsion
durable power of attorney
kcalories in 360 mL of a 20% lipid emulsion
advance directive
refers to the concentration of solutes per liter of solution
396
refers to the concentration of solutes per liter of solution
578
refers to the concentration of solutes per liter of solution
total parenteral nutrition
refers to the concentration of solutes per liter of solution
piggyback
refers to the concentration of solutes per liter of solution
continuous parenteral nutrition
refers to the concentration of solutes per liter of solution
osmolality
refers to the concentration of solutes per liter of solution
peripheral veins
refers to the concentration of solutes per liter of solution
central veins
refers to the concentration of solutes per liter of solution
total nutrient admixture
refers to the concentration of solutes per liter of solution
720
refers to the concentration of solutes per liter of solution
cyclic parenteral nutrition
refers to the concentration of solutes per liter of solution
peripheral parenteral nutrition
refers to the concentration of solutes per liter of solution
2-in-1 solution
refers to the concentration of solutes per liter of solution
osmolarity
refers to the concentration of solutes per liter of solution
refeeding syndrome
refers to the concentration of solutes per liter of solution
durable power of attorney
refers to the concentration of solutes per liter of solution
advance directive
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
396
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
578
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
total parenteral nutrition
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
piggyback
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
continuous parenteral nutrition
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
osmolality
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
peripheral veins
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
central veins
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
total nutrient admixture
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
720
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
cyclic parenteral nutrition
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
peripheral parenteral nutrition
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
2-in-1 solution
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
osmolarity
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
refeeding syndrome
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
durable power of attorney
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
advance directive
small-diameter veins that carry blood from the arms and legs
396
small-diameter veins that carry blood from the arms and legs
578
small-diameter veins that carry blood from the arms and legs
total parenteral nutrition
small-diameter veins that carry blood from the arms and legs
piggyback
small-diameter veins that carry blood from the arms and legs
continuous parenteral nutrition
small-diameter veins that carry blood from the arms and legs
osmolality
small-diameter veins that carry blood from the arms and legs
peripheral veins
small-diameter veins that carry blood from the arms and legs
central veins
small-diameter veins that carry blood from the arms and legs
total nutrient admixture
small-diameter veins that carry blood from the arms and legs
720
small-diameter veins that carry blood from the arms and legs
cyclic parenteral nutrition
small-diameter veins that carry blood from the arms and legs
peripheral parenteral nutrition
small-diameter veins that carry blood from the arms and legs
2-in-1 solution
small-diameter veins that carry blood from the arms and legs
osmolarity
small-diameter veins that carry blood from the arms and legs
refeeding syndrome
small-diameter veins that carry blood from the arms and legs
durable power of attorney
small-diameter veins that carry blood from the arms and legs
advance directive
type of nutrition support that usually has a maximum of 900 mOsm/L
396
type of nutrition support that usually has a maximum of 900 mOsm/L
578
type of nutrition support that usually has a maximum of 900 mOsm/L
total parenteral nutrition
type of nutrition support that usually has a maximum of 900 mOsm/L
piggyback
type of nutrition support that usually has a maximum of 900 mOsm/L
continuous parenteral nutrition
type of nutrition support that usually has a maximum of 900 mOsm/L
osmolality
type of nutrition support that usually has a maximum of 900 mOsm/L
peripheral veins
type of nutrition support that usually has a maximum of 900 mOsm/L
central veins
type of nutrition support that usually has a maximum of 900 mOsm/L
total nutrient admixture
type of nutrition support that usually has a maximum of 900 mOsm/L
720
type of nutrition support that usually has a maximum of 900 mOsm/L
cyclic parenteral nutrition
type of nutrition support that usually has a maximum of 900 mOsm/L
peripheral parenteral nutrition
type of nutrition support that usually has a maximum of 900 mOsm/L
2-in-1 solution
type of nutrition support that usually has a maximum of 900 mOsm/L
osmolarity
type of nutrition support that usually has a maximum of 900 mOsm/L
refeeding syndrome
type of nutrition support that usually has a maximum of 900 mOsm/L
durable power of attorney
type of nutrition support that usually has a maximum of 900 mOsm/L
advance directive
parenteral solution that contains dextrose and amino acids, and excludes lipids
396
parenteral solution that contains dextrose and amino acids, and excludes lipids
578
parenteral solution that contains dextrose and amino acids, and excludes lipids
total parenteral nutrition
parenteral solution that contains dextrose and amino acids, and excludes lipids
piggyback
parenteral solution that contains dextrose and amino acids, and excludes lipids
continuous parenteral nutrition
parenteral solution that contains dextrose and amino acids, and excludes lipids
osmolality
parenteral solution that contains dextrose and amino acids, and excludes lipids
peripheral veins
parenteral solution that contains dextrose and amino acids, and excludes lipids
central veins
parenteral solution that contains dextrose and amino acids, and excludes lipids
total nutrient admixture
parenteral solution that contains dextrose and amino acids, and excludes lipids
720
parenteral solution that contains dextrose and amino acids, and excludes lipids
cyclic parenteral nutrition
parenteral solution that contains dextrose and amino acids, and excludes lipids
peripheral parenteral nutrition
parenteral solution that contains dextrose and amino acids, and excludes lipids
2-in-1 solution
parenteral solution that contains dextrose and amino acids, and excludes lipids
osmolarity
parenteral solution that contains dextrose and amino acids, and excludes lipids
refeeding syndrome
parenteral solution that contains dextrose and amino acids, and excludes lipids
durable power of attorney
parenteral solution that contains dextrose and amino acids, and excludes lipids
advance directive
continuous administration of parenteral solution over 24 hours
396
continuous administration of parenteral solution over 24 hours
578
continuous administration of parenteral solution over 24 hours
total parenteral nutrition
continuous administration of parenteral solution over 24 hours
piggyback
continuous administration of parenteral solution over 24 hours
continuous parenteral nutrition
continuous administration of parenteral solution over 24 hours
osmolality
continuous administration of parenteral solution over 24 hours
peripheral veins
continuous administration of parenteral solution over 24 hours
central veins
continuous administration of parenteral solution over 24 hours
total nutrient admixture
continuous administration of parenteral solution over 24 hours
720
continuous administration of parenteral solution over 24 hours
cyclic parenteral nutrition
continuous administration of parenteral solution over 24 hours
peripheral parenteral nutrition
continuous administration of parenteral solution over 24 hours
2-in-1 solution
continuous administration of parenteral solution over 24 hours
osmolarity
continuous administration of parenteral solution over 24 hours
refeeding syndrome
continuous administration of parenteral solution over 24 hours
durable power of attorney
continuous administration of parenteral solution over 24 hours
advance directive
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
396
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
578
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
total parenteral nutrition
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
piggyback
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
continuous parenteral nutrition
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
osmolality
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
peripheral veins
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
central veins
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
total nutrient admixture
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
720
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
cyclic parenteral nutrition
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
peripheral parenteral nutrition
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
2-in-1 solution
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
osmolarity
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
refeeding syndrome
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
durable power of attorney
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
advance directive
large-diameter veins close to the heart
396
large-diameter veins close to the heart
578
large-diameter veins close to the heart
total parenteral nutrition
large-diameter veins close to the heart
piggyback
large-diameter veins close to the heart
continuous parenteral nutrition
large-diameter veins close to the heart
osmolality
large-diameter veins close to the heart
peripheral veins
large-diameter veins close to the heart
central veins
large-diameter veins close to the heart
total nutrient admixture
large-diameter veins close to the heart
720
large-diameter veins close to the heart
cyclic parenteral nutrition
large-diameter veins close to the heart
peripheral parenteral nutrition
large-diameter veins close to the heart
2-in-1 solution
large-diameter veins close to the heart
osmolarity
large-diameter veins close to the heart
refeeding syndrome
large-diameter veins close to the heart
durable power of attorney
large-diameter veins close to the heart
advance directive
kcalories in 360 mL of a 10% lipid emulsion
396
kcalories in 360 mL of a 10% lipid emulsion
578
kcalories in 360 mL of a 10% lipid emulsion
total parenteral nutrition
kcalories in 360 mL of a 10% lipid emulsion
piggyback
kcalories in 360 mL of a 10% lipid emulsion
continuous parenteral nutrition
kcalories in 360 mL of a 10% lipid emulsion
osmolality
kcalories in 360 mL of a 10% lipid emulsion
peripheral veins
kcalories in 360 mL of a 10% lipid emulsion
central veins
kcalories in 360 mL of a 10% lipid emulsion
total nutrient admixture
kcalories in 360 mL of a 10% lipid emulsion
720
kcalories in 360 mL of a 10% lipid emulsion
cyclic parenteral nutrition
kcalories in 360 mL of a 10% lipid emulsion
peripheral parenteral nutrition
kcalories in 360 mL of a 10% lipid emulsion
2-in-1 solution
kcalories in 360 mL of a 10% lipid emulsion
osmolarity
kcalories in 360 mL of a 10% lipid emulsion
refeeding syndrome
kcalories in 360 mL of a 10% lipid emulsion
durable power of attorney
kcalories in 360 mL of a 10% lipid emulsion
advance directive
parenteral solution that contains dextrose, amino acids, and lipids
396
parenteral solution that contains dextrose, amino acids, and lipids
578
parenteral solution that contains dextrose, amino acids, and lipids
total parenteral nutrition
parenteral solution that contains dextrose, amino acids, and lipids
piggyback
parenteral solution that contains dextrose, amino acids, and lipids
continuous parenteral nutrition
parenteral solution that contains dextrose, amino acids, and lipids
osmolality
parenteral solution that contains dextrose, amino acids, and lipids
peripheral veins
parenteral solution that contains dextrose, amino acids, and lipids
central veins
parenteral solution that contains dextrose, amino acids, and lipids
total nutrient admixture
parenteral solution that contains dextrose, amino acids, and lipids
720
parenteral solution that contains dextrose, amino acids, and lipids
cyclic parenteral nutrition
parenteral solution that contains dextrose, amino acids, and lipids
peripheral parenteral nutrition
parenteral solution that contains dextrose, amino acids, and lipids
2-in-1 solution
parenteral solution that contains dextrose, amino acids, and lipids
osmolarity
parenteral solution that contains dextrose, amino acids, and lipids
refeeding syndrome
parenteral solution that contains dextrose, amino acids, and lipids
durable power of attorney
parenteral solution that contains dextrose, amino acids, and lipids
advance directive
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
396
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
578
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
total parenteral nutrition
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
piggyback
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
continuous parenteral nutrition
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
osmolality
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
peripheral veins
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
central veins
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
total nutrient admixture
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
720
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
cyclic parenteral nutrition
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
peripheral parenteral nutrition
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
2-in-1 solution
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
osmolarity
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
refeeding syndrome
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
durable power of attorney
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
advance directive
type of nutrition support in which the nutrient concentrations do not need to be limited
396
type of nutrition support in which the nutrient concentrations do not need to be limited
578
type of nutrition support in which the nutrient concentrations do not need to be limited
total parenteral nutrition
type of nutrition support in which the nutrient concentrations do not need to be limited
piggyback
type of nutrition support in which the nutrient concentrations do not need to be limited
continuous parenteral nutrition
type of nutrition support in which the nutrient concentrations do not need to be limited
osmolality
type of nutrition support in which the nutrient concentrations do not need to be limited
peripheral veins
type of nutrition support in which the nutrient concentrations do not need to be limited
central veins
type of nutrition support in which the nutrient concentrations do not need to be limited
total nutrient admixture
type of nutrition support in which the nutrient concentrations do not need to be limited
720
type of nutrition support in which the nutrient concentrations do not need to be limited
cyclic parenteral nutrition
type of nutrition support in which the nutrient concentrations do not need to be limited
peripheral parenteral nutrition
type of nutrition support in which the nutrient concentrations do not need to be limited
2-in-1 solution
type of nutrition support in which the nutrient concentrations do not need to be limited
osmolarity
type of nutrition support in which the nutrient concentrations do not need to be limited
refeeding syndrome
type of nutrition support in which the nutrient concentrations do not need to be limited
durable power of attorney
type of nutrition support in which the nutrient concentrations do not need to be limited
advance directive
refers to the concentration of solutes per kilogram of water
396
refers to the concentration of solutes per kilogram of water
578
refers to the concentration of solutes per kilogram of water
total parenteral nutrition
refers to the concentration of solutes per kilogram of water
piggyback
refers to the concentration of solutes per kilogram of water
continuous parenteral nutrition
refers to the concentration of solutes per kilogram of water
osmolality
refers to the concentration of solutes per kilogram of water
peripheral veins
refers to the concentration of solutes per kilogram of water
central veins
refers to the concentration of solutes per kilogram of water
total nutrient admixture
refers to the concentration of solutes per kilogram of water
720
refers to the concentration of solutes per kilogram of water
cyclic parenteral nutrition
refers to the concentration of solutes per kilogram of water
peripheral parenteral nutrition
refers to the concentration of solutes per kilogram of water
2-in-1 solution
refers to the concentration of solutes per kilogram of water
osmolarity
refers to the concentration of solutes per kilogram of water
refeeding syndrome
refers to the concentration of solutes per kilogram of water
durable power of attorney
refers to the concentration of solutes per kilogram of water
advance directive
energy content of 1 L of a parenteral solution that contains 17% dextrose
396
energy content of 1 L of a parenteral solution that contains 17% dextrose
578
energy content of 1 L of a parenteral solution that contains 17% dextrose
total parenteral nutrition
energy content of 1 L of a parenteral solution that contains 17% dextrose
piggyback
energy content of 1 L of a parenteral solution that contains 17% dextrose
continuous parenteral nutrition
energy content of 1 L of a parenteral solution that contains 17% dextrose
osmolality
energy content of 1 L of a parenteral solution that contains 17% dextrose
peripheral veins
energy content of 1 L of a parenteral solution that contains 17% dextrose
central veins
energy content of 1 L of a parenteral solution that contains 17% dextrose
total nutrient admixture
energy content of 1 L of a parenteral solution that contains 17% dextrose
720
energy content of 1 L of a parenteral solution that contains 17% dextrose
cyclic parenteral nutrition
energy content of 1 L of a parenteral solution that contains 17% dextrose
peripheral parenteral nutrition
energy content of 1 L of a parenteral solution that contains 17% dextrose
2-in-1 solution
energy content of 1 L of a parenteral solution that contains 17% dextrose
osmolarity
energy content of 1 L of a parenteral solution that contains 17% dextrose
refeeding syndrome
energy content of 1 L of a parenteral solution that contains 17% dextrose
durable power of attorney
energy content of 1 L of a parenteral solution that contains 17% dextrose
advance directive
administration of a second solution using a separate port in an intravenous catheter
396
administration of a second solution using a separate port in an intravenous catheter
578
administration of a second solution using a separate port in an intravenous catheter
total parenteral nutrition
administration of a second solution using a separate port in an intravenous catheter
piggyback
administration of a second solution using a separate port in an intravenous catheter
continuous parenteral nutrition
administration of a second solution using a separate port in an intravenous catheter
osmolality
administration of a second solution using a separate port in an intravenous catheter
peripheral veins
administration of a second solution using a separate port in an intravenous catheter
central veins
administration of a second solution using a separate port in an intravenous catheter
total nutrient admixture
administration of a second solution using a separate port in an intravenous catheter
720
administration of a second solution using a separate port in an intravenous catheter
cyclic parenteral nutrition
administration of a second solution using a separate port in an intravenous catheter
peripheral parenteral nutrition
administration of a second solution using a separate port in an intravenous catheter
2-in-1 solution
administration of a second solution using a separate port in an intravenous catheter
osmolarity
administration of a second solution using a separate port in an intravenous catheter
refeeding syndrome
administration of a second solution using a separate port in an intravenous catheter
durable power of attorney
administration of a second solution using a separate port in an intravenous catheter
advance directive
administration of a parenteral solution over an 8- to 14-hour period
396
administration of a parenteral solution over an 8- to 14-hour period
578
administration of a parenteral solution over an 8- to 14-hour period
total parenteral nutrition
administration of a parenteral solution over an 8- to 14-hour period
piggyback
administration of a parenteral solution over an 8- to 14-hour period
continuous parenteral nutrition
administration of a parenteral solution over an 8- to 14-hour period
osmolality
administration of a parenteral solution over an 8- to 14-hour period
peripheral veins
administration of a parenteral solution over an 8- to 14-hour period
central veins
administration of a parenteral solution over an 8- to 14-hour period
total nutrient admixture
administration of a parenteral solution over an 8- to 14-hour period
720
administration of a parenteral solution over an 8- to 14-hour period
cyclic parenteral nutrition
administration of a parenteral solution over an 8- to 14-hour period
peripheral parenteral nutrition
administration of a parenteral solution over an 8- to 14-hour period
2-in-1 solution
administration of a parenteral solution over an 8- to 14-hour period
osmolarity
administration of a parenteral solution over an 8- to 14-hour period
refeeding syndrome
administration of a parenteral solution over an 8- to 14-hour period
durable power of attorney
administration of a parenteral solution over an 8- to 14-hour period
advance directive
Question
Questions 65-68 Short Case Study
Elena Hayes is a 64-year-old realtor. She has been admitted to the local medical center six times in the past 3 months with severe pancreatitis. Elena has been experiencing intractable vomiting and intense pain after eating. Her insurance will not cover home nutritional support. She is being transferred to a subacute nursing facility for therapy.
The registered dietitian completing Elena's initial assessment should expect which result?

A) high albumin
B) weight loss
C) high iron
D) low insulin
Question
Discuss possible metabolic complications associated with parenteral nutrition and suggest ways to correct such complications.
Question
The do-not-resuscitate (DNR) order is most often used in patients for whom ____.

A) death is expected and inevitable
B) treatment is excessively costly and not reimbursable
C) organ procurement is in progress
D) families have requested it
Question
Questions 65-68 Short Case Study
Elena Hayes is a 64-year-old realtor. She has been admitted to the local medical center six times in the past 3 months with severe pancreatitis. Elena has been experiencing intractable vomiting and intense pain after eating. Her insurance will not cover home nutritional support. She is being transferred to a subacute nursing facility for therapy.
Upon admission, Elena tells her nurse that she has a lot of fear with regard to nutrition support because she experienced a "vein blowout" at a previous admission. What is the most likely cause of this incident?

A) high glucose in the TPN
B) low amino acids in the TPN
C) low vitamin K in the PPN
D) high osmolarity of the PPN
Question
Questions 62-64 Short Case-study  
 
Devon Young is a 30-year-old single male who exercises and follows a healthy diet. His physician admits Devon to the medical-surgical unit for evaluation of reported symptoms of poor appetite, constipation, nausea, and vomiting for 3 days.
After surgery, Devon remains on ventilator support but his gut function is improving. The doctor should initiate ____.

A) a soft diet
B) a clear liquid diet
C) elemental tube feeding
D) PPN
Question
Define refeeding syndrome. Why does it occur and how can it be prevented?
Question
Discuss the quality-of-life issues that need to be addressed with patients receiving long-term nutrition support at home.
Question
Discuss the use of carbohydrates in parenteral nutrition.
Question
Questions 65-68 Short Case Study
Elena Hayes is a 64-year-old realtor. She has been admitted to the local medical center six times in the past 3 months with severe pancreatitis. Elena has been experiencing intractable vomiting and intense pain after eating. Her insurance will not cover home nutritional support. She is being transferred to a subacute nursing facility for therapy.
Laboratory values indicate that Elena's blood glucose is extremely high. Which nutrient component of her total parenteral nutrition must be adjusted?

A) water
B) dextrose
C) amino acids
D) chromium
Question
Questions 65-68 Short Case Study
Elena Hayes is a 64-year-old realtor. She has been admitted to the local medical center six times in the past 3 months with severe pancreatitis. Elena has been experiencing intractable vomiting and intense pain after eating. Her insurance will not cover home nutritional support. She is being transferred to a subacute nursing facility for therapy.
The nutrition support team decides to increase the kcal in Ms. Hayes's total parenteral nutrition slowly to prevent ____.

A) hypoglycemia
B) an elevated white blood cell count
C) refeeding syndrome
D) weight gain
Question
Compare and contrast peripheral parenteral nutrition and total parenteral nutrition.
Question
Questions 62-64 Short Case-study  
 
Devon Young is a 30-year-old single male who exercises and follows a healthy diet. His physician admits Devon to the medical-surgical unit for evaluation of reported symptoms of poor appetite, constipation, nausea, and vomiting for 3 days.
Upon admission, what diet is most appropriate for Devon until he receives further testing?

A) nothing by mouth
B) low sodium
C) low fiber
D) high protein/high kcalorie
Question
Questions 62-64 Short Case-study  
 
Devon Young is a 30-year-old single male who exercises and follows a healthy diet. His physician admits Devon to the medical-surgical unit for evaluation of reported symptoms of poor appetite, constipation, nausea, and vomiting for 3 days.
Devon will need intestinal surgery and will be receiving nothing by mouth for 15 to 20 days. How can his medical team meet his nutritional needs during this time?

A) regular diet
B) elemental formula
C) enteral nutrition
D) parenteral nutrition
Unlock Deck
Sign up to unlock the cards in this deck!
Unlock Deck
Unlock Deck
1/74
auto play flashcards
Play
simple tutorial
Full screen (f)
exit full mode
Deck 21: Parenteral Nutrition Support
1
Traditionally, central catheters enter the circulation at the ____ vein and are threaded into the superior vena cava with the tip of the catheter lying close to the heart.

A) brachial
B) right subclavian
C) basilic
D) cephalic
B
2
Delivery of nutrient solutions directly into the vein is called ____.

A) standard nutrition
B) enteral nutrition
C) parenteral nutrition
D) tube feeding
C
3
Redness, swelling, and tenderness at the infusion site of a vein is described as ____.

A) hematoma
B) phlebitis
C) infiltration
D) nerve damage
B
4
A 21-year-old athlete who has a nonfunctional gastrointestinal tract is scheduled for major gastric surgery in 3 weeks. His energy and nutrient needs are higher than those of the average person his age, but his fluid intake is restricted. What would be the preferred method of feeding for this patient in order to keep him well nourished until surgery?

A) clear liquids
B) peripheral parenteral nutrition
C) total parenteral nutrition
D) mechanically soft diet
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
5
The large-diameter central veins are located near the ____.

A) extremities
B) heart
C) liver
D) lungs
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
6
Dextrose concentrations of ____ percent or lower can be used for peripheral parenteral nutrition solutions.

A) 10
B) 30
C) 50
D) 70
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
7
What is an advantage of total parenteral nutrition?

A) Nutrient concentrations do not need to be limited.
B) It accesses only peripheral veins.
C) Patients who require only brief support (7 to 10 days) can use it.
D) It is less invasive.
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
8
The small-diameter veins that are used for peripheral parenteral nutrition carry blood from the ___________.

A) heart
B) limbs
C) kidneys
D) brain
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
9
Which statement regarding peripheral insertion of central catheters is false?

A) It is lower in cost
B) It is less invasive
C) It enters the circulation at the basilica vein
D) It enters the circulation at the right subclavian vein
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
10
The protein in a total parenteral nutrition solution is primarily in the form of ____.

A) amino acids
B) protein hydrolysate
C) short-chain fatty acids
D) intact protein
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
11
Peripheral parenteral nutrition is most often used in patients who require nutrition support for less than ____.

A) 2 weeks
B) 6 weeks
C) 3 months
D) 6 months
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
12
Osmolality refers to milliosmoles of ions and molecules per _____

A) liter of solution (mOsm/L)
B) kilogram of solvent (mOsm/kg)
C) kilogram of solution (mOsm/kg)
D) liter of solvent (mOsm/L)
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
13
Osmolarity refers to milliosmoles of ions and molecules per ____.

A) liter of solution (mOsm/L)
B) kilogram of solvent (mOsm/kg)
C) kilogram of solution (mOsm/kg)
D) liter of solvent (mOsm/L)
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
14
Parenteral nutrition would most likely be contraindicated in which condition?

A) paralytic ileus
B) GI bleeding
C) severe hyperglycemia
D) intractable vomiting
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
15
The use of peripheral parenteral nutrition is not recommended in a patient with ____.

A) a partially functioning GI tract
B) low pain tolerance
C) weak peripheral veins
D) a swallowing disorder
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
16
Which form of glucose is typically used in parenteral solutions?

A) dextrose
B) fructose
C) lactose
D) galactose
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
17
To prevent phlebitis, the osmolarity of parenteral solutions used for peripheral parenteral nutrition is generally kept below ____ milliosmoles per liter.

A) 300
B) 600
C) 900
D) 1200
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
18
How much energy does dextrose provide?

A) 3.4 kcal/g
B) 4.0 kcal/g
C) 4.4 kcal/g
D) 5.0 kcal/g
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
19
The movement of water across biological membranes is known as ____.

A) osmosis
B) peripheral transport
C) diffusion
D) absorption
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
20
Osmolality is usually derived by using ____.

A) equations that account for the nutrients and electrolytes
B) the weights of the nutrients and solution
C) an instrument called an osmometer
D) an instrument called a spectrometer
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
21
To prevent bacterial contamination and maintain stability, parenteral solutions are ____.

A) warmed to room temperature prior to infusion
B) exposed to light
C) pasteurized
D) compounded in the pharmacy under aseptic conditions
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
22
How many kcalories are provided by 3 L of a 5% dextrose solution?

A) 150
B) 510
C) 600
D) 660
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
23
The approximate osmolarity of a 1-L solution that contains 35 g of amino acids, 200 g of dextrose, 20 g of lipids from a 20% fat emulsion, and 150 mEq and mmol of electrolytes would be __________ mOsm/L.

A) 1039.4
B) 1339.2
C) 1514.2
D) 1729.4
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
24
How many grams of amino acids would be provided to a client receiving 2000 mL of a 5% amino acid solution?

A) 50
B) 100
C) 200
D) 400
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
25
Why are few medications added to parenteral solutions?

A) to avoid potential drug-nutrient interactions
B) because too many can destabilize the dextrose
C) because they are unnecessary if the solution is properly balanced
D) because it is not possible to do so
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
26
Approximately how many liters of fluids will be required by a stable adult patient weighing 81 kg?

A) 1.4 to 2.2 L
B) 2.4 to 3.2 L
C) 3.2 to 4.0 L
D) 4.0 to 4.4 L
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
27
The administration of a second solution using a separate port is called a ____.

A) Y-connector
B) piggyback
C) double-lumen tube
D) distal port
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
28
Caution should be taken when administering parenteral lipids to people with which condition?

A) hypertriglyceridemia
B) hyperglycemia
C) diabetes
D) kidney failure
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
29
Which vitamin is omitted from parenteral solutions prescribed for patients on warfarin therapy?

A) C
B) D
C) E
D) K
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
30
Which macronutrient is usually the main source of energy in parenteral nutrition?

A) carbohydrate
B) protein
C) fat
D) amino acids
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
31
The energy content of 2 L of a parenteral solution that contains 22% dextrose and 15% amino acids supplemented with 300 mL of a 10% lipid emulsion is _________ kcalories

A) 1696
B) 2696
C) 3696
D) 4696
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
32
Daily fluid needs range from ____ mL per kilogram of body weight in most stable patients.

A) 5 to 15
B) 15 to 25
C) 30 to 40
D) 35 to 45
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
33
A physician writes an order for a patient to receive lipid emulsions via total parenteral nutrition twice a week. The purpose of this order to supply lipids is mainly to ____.

A) provide essential fatty acids
B) provide nonessential amino acids
C) provide essential minerals
D) suppress the immune response
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
34
Although the administration of 3-in-1 solutions is simpler because only one infusion pump is required, what can occur when lipid emulsions have been added?

A) The solution is too dense to use in a central vein.
B) The solution causes platelet aggregation.
C) The solution often becomes contaminated.
D) The solution can form large lipid droplets.
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
35
Cyclic parenteral nutrition is administered over ____ hours per day.

A) 3 to 6
B) 6 to 8
C) 8 to 14
D) 12 to 18
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
36
Which trace mineral is typically excluded from parenteral solutions because it alters the stability of the other ingredients in the solution?

A) zinc
B) copper
C) iron
D) selenium
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
37
Which condition describes a metabolic complication of parenteral nutrition?

A) hypoglycemia
B) phlebitis
C) air embolism
D) sepsis
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
38
A 3-in-1 solution that contains amino acids, lipids, and dextrose is also called a ____.

A) hydrolyzed solution
B) total nutrient admixture
C) elemental suspension
D) isotonic solution
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
39
Which type of oil most commonly makes up the triglycerides in lipid emulsions?

A) corn oil
B) sunflower oil
C) soybean oil
D) coconut oil
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
40
One major benefit of cyclic infusion of total parenteral nutrition is ____.

A) maintenance of high insulin levels
B) increase in fat stores
C) more freedom of movement during the day
D) achievement of a negative nitrogen balance
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
41
Which type of parenteral nutrition provided at night allows patients to participate in routine activities during the day?

A) continuous
B) cyclic
C) peripheral
D) piggyback
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
42
Before parenteral nutrition is discontinued, oral intake, tube feeding, or a combination of both should provide at least _____ percent of the estimated energy needs.

A) 40 to 50
B) 55 to 60
C) 60 to 75
D) 90 to 95
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
43
Which statement is true of Terri's Law?

A) It allows hospitals to withdraw life-sustaining treatment against the wishes of the family.
B) It allowed the governor to order hospitals to withdraw life-sustaining treatment against the wishes of the family, but was found unconstitutional.
C) It allows hospitals to continue life-sustaining treatment against the wishes of the family.
D) It allowed the governor to intervene and act against a family's wishes in order to continue life-sustaining treatment, but was found unconstitutional.
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
44
A patient should be fully informed of a treatment's benefits and risks in a fair and honest manner. If the patient agrees to the proposed treatment, it is referred to as ____.

A) autonomy
B) informed consent
C) beneficence
D) distributive justice
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
45
When providers consider whether provision of health care for one patient would unfairly limit the care of other patients, ____ is being considered.

A) autonomy
B) informed consent
C) beneficence
D) distributive justice
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
46
The enteral formula used for home nutrition is most often influenced by cost and ____.

A) taste
B) availability
C) efficiency of administration
D) appearance
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
47
A 12-year-old patient is being weaned off of total parenteral nutrition. In addition to total parenteral nutrition, he is on a soft diet. The patient is 5 ft 2 in. tall and weighs 110 lb. His energy needs are estimated to be approximately 2100 kcal/day. His kcalorie count reveals he is consuming 1700 kcal/day. Which intervention is appropriate at this time?

A) Discontinue TPN.
B) Double his oral feedings.
C) Consider enteral feedings.
D) Increase TPN to provide an additional 1100 kcal.
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
48
Shawna is on home total parenteral nutrition and is having trouble adjusting to the changes in her life. Which organization does the text recommend as a good source of support and information for her?

A) Oley Foundation
B) P-CAN
C) Livestrong
D) ACS
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
49
One of the greatest concerns of patients who use home nutrition support is the ____.

A) inability to consume meals with friends
B) appearance of the tube
C) risks of the tube becoming clogged
D) inability to choose the type and amount of formula delivered
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
50
Liver enzymes should be monitored ____ during parenteral support.

A) hourly
B) daily
C) weekly
D) every 2 weeks
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
51
How often should the fluid intake and output of a patient on total parenteral nutrition be checked?

A) before starting
B) every 4 to 8 hours
C) daily
D) once a week
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
52
Refeeding syndrome is characterized by fluid and electrolyte imbalances and ____.

A) systemic infection
B) hypothyroidism
C) severe weight loss
D) hyperglycemia
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
53
Which condition describes a catheter-related complication of parenteral nutrition?

A) refeeding syndrome
B) gallbladder disease
C) air embolism
D) nutrient deficiencies
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
54
What best describes the role of the nurse on the nutrition support team?

A) diagnosing nutrition problems
B) recommending the appropriate diet
C) performing direct patient care
D) recommending appropriate drug therapy
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
55
The health care team has just ordered total parenteral nutrition for Mr. Calabria. He is a 58-year-old man who is suffering from intractable diarrhea. Before Mr. Calabria starts TPN, what procedure should be performed?

A) X-ray to confirm catheter placement
B) body mass index assessment
C) calcium balance
D) hand grip strength
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
56
A female patient who is on long-term parenteral nutrition is at risk for ____.

A) type 1 diabetes
B) osteoporosis
C) liver cancer
D) heart disease
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
57
In which situation would home total parenteral nutrition be an appropriate means for maintaining adequate nutrition status?

A) an individual with dysphagia
B) an individual with chronic intestinal obstruction
C) an individual with head and neck cancer
D) an individual with neurological impairment affecting the esophagus
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
58
The potential good that can come from a proposed treatment is referred to as ____.

A) autonomy
B) informed consent
C) beneficence
D) distributive justice
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
59
When refrigerated, ready-made parenteral solutions may be stable for ____.

A) 1 week
B) 10 days
C) 2 weeks
D) 3 weeks
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
60
A patient on total parenteral nutrition for longer than a few ____ is at risk for "sludge" buildup in the gallbladder and gallstone formation.

A) hours
B) days
C) weeks
D) months
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
61
Match between columns
kcalories in 360 mL of a 20% lipid emulsion
396
kcalories in 360 mL of a 20% lipid emulsion
578
kcalories in 360 mL of a 20% lipid emulsion
total parenteral nutrition
kcalories in 360 mL of a 20% lipid emulsion
piggyback
kcalories in 360 mL of a 20% lipid emulsion
continuous parenteral nutrition
kcalories in 360 mL of a 20% lipid emulsion
osmolality
kcalories in 360 mL of a 20% lipid emulsion
peripheral veins
kcalories in 360 mL of a 20% lipid emulsion
central veins
kcalories in 360 mL of a 20% lipid emulsion
total nutrient admixture
kcalories in 360 mL of a 20% lipid emulsion
720
kcalories in 360 mL of a 20% lipid emulsion
cyclic parenteral nutrition
kcalories in 360 mL of a 20% lipid emulsion
peripheral parenteral nutrition
kcalories in 360 mL of a 20% lipid emulsion
2-in-1 solution
kcalories in 360 mL of a 20% lipid emulsion
osmolarity
kcalories in 360 mL of a 20% lipid emulsion
refeeding syndrome
kcalories in 360 mL of a 20% lipid emulsion
durable power of attorney
kcalories in 360 mL of a 20% lipid emulsion
advance directive
refers to the concentration of solutes per liter of solution
396
refers to the concentration of solutes per liter of solution
578
refers to the concentration of solutes per liter of solution
total parenteral nutrition
refers to the concentration of solutes per liter of solution
piggyback
refers to the concentration of solutes per liter of solution
continuous parenteral nutrition
refers to the concentration of solutes per liter of solution
osmolality
refers to the concentration of solutes per liter of solution
peripheral veins
refers to the concentration of solutes per liter of solution
central veins
refers to the concentration of solutes per liter of solution
total nutrient admixture
refers to the concentration of solutes per liter of solution
720
refers to the concentration of solutes per liter of solution
cyclic parenteral nutrition
refers to the concentration of solutes per liter of solution
peripheral parenteral nutrition
refers to the concentration of solutes per liter of solution
2-in-1 solution
refers to the concentration of solutes per liter of solution
osmolarity
refers to the concentration of solutes per liter of solution
refeeding syndrome
refers to the concentration of solutes per liter of solution
durable power of attorney
refers to the concentration of solutes per liter of solution
advance directive
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
396
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
578
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
total parenteral nutrition
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
piggyback
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
continuous parenteral nutrition
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
osmolality
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
peripheral veins
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
central veins
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
total nutrient admixture
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
720
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
cyclic parenteral nutrition
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
peripheral parenteral nutrition
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
2-in-1 solution
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
osmolarity
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
refeeding syndrome
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
durable power of attorney
written or oral instruction regarding one's preferences for medical treatment to be used in the event that a person becomes incapacitated
advance directive
small-diameter veins that carry blood from the arms and legs
396
small-diameter veins that carry blood from the arms and legs
578
small-diameter veins that carry blood from the arms and legs
total parenteral nutrition
small-diameter veins that carry blood from the arms and legs
piggyback
small-diameter veins that carry blood from the arms and legs
continuous parenteral nutrition
small-diameter veins that carry blood from the arms and legs
osmolality
small-diameter veins that carry blood from the arms and legs
peripheral veins
small-diameter veins that carry blood from the arms and legs
central veins
small-diameter veins that carry blood from the arms and legs
total nutrient admixture
small-diameter veins that carry blood from the arms and legs
720
small-diameter veins that carry blood from the arms and legs
cyclic parenteral nutrition
small-diameter veins that carry blood from the arms and legs
peripheral parenteral nutrition
small-diameter veins that carry blood from the arms and legs
2-in-1 solution
small-diameter veins that carry blood from the arms and legs
osmolarity
small-diameter veins that carry blood from the arms and legs
refeeding syndrome
small-diameter veins that carry blood from the arms and legs
durable power of attorney
small-diameter veins that carry blood from the arms and legs
advance directive
type of nutrition support that usually has a maximum of 900 mOsm/L
396
type of nutrition support that usually has a maximum of 900 mOsm/L
578
type of nutrition support that usually has a maximum of 900 mOsm/L
total parenteral nutrition
type of nutrition support that usually has a maximum of 900 mOsm/L
piggyback
type of nutrition support that usually has a maximum of 900 mOsm/L
continuous parenteral nutrition
type of nutrition support that usually has a maximum of 900 mOsm/L
osmolality
type of nutrition support that usually has a maximum of 900 mOsm/L
peripheral veins
type of nutrition support that usually has a maximum of 900 mOsm/L
central veins
type of nutrition support that usually has a maximum of 900 mOsm/L
total nutrient admixture
type of nutrition support that usually has a maximum of 900 mOsm/L
720
type of nutrition support that usually has a maximum of 900 mOsm/L
cyclic parenteral nutrition
type of nutrition support that usually has a maximum of 900 mOsm/L
peripheral parenteral nutrition
type of nutrition support that usually has a maximum of 900 mOsm/L
2-in-1 solution
type of nutrition support that usually has a maximum of 900 mOsm/L
osmolarity
type of nutrition support that usually has a maximum of 900 mOsm/L
refeeding syndrome
type of nutrition support that usually has a maximum of 900 mOsm/L
durable power of attorney
type of nutrition support that usually has a maximum of 900 mOsm/L
advance directive
parenteral solution that contains dextrose and amino acids, and excludes lipids
396
parenteral solution that contains dextrose and amino acids, and excludes lipids
578
parenteral solution that contains dextrose and amino acids, and excludes lipids
total parenteral nutrition
parenteral solution that contains dextrose and amino acids, and excludes lipids
piggyback
parenteral solution that contains dextrose and amino acids, and excludes lipids
continuous parenteral nutrition
parenteral solution that contains dextrose and amino acids, and excludes lipids
osmolality
parenteral solution that contains dextrose and amino acids, and excludes lipids
peripheral veins
parenteral solution that contains dextrose and amino acids, and excludes lipids
central veins
parenteral solution that contains dextrose and amino acids, and excludes lipids
total nutrient admixture
parenteral solution that contains dextrose and amino acids, and excludes lipids
720
parenteral solution that contains dextrose and amino acids, and excludes lipids
cyclic parenteral nutrition
parenteral solution that contains dextrose and amino acids, and excludes lipids
peripheral parenteral nutrition
parenteral solution that contains dextrose and amino acids, and excludes lipids
2-in-1 solution
parenteral solution that contains dextrose and amino acids, and excludes lipids
osmolarity
parenteral solution that contains dextrose and amino acids, and excludes lipids
refeeding syndrome
parenteral solution that contains dextrose and amino acids, and excludes lipids
durable power of attorney
parenteral solution that contains dextrose and amino acids, and excludes lipids
advance directive
continuous administration of parenteral solution over 24 hours
396
continuous administration of parenteral solution over 24 hours
578
continuous administration of parenteral solution over 24 hours
total parenteral nutrition
continuous administration of parenteral solution over 24 hours
piggyback
continuous administration of parenteral solution over 24 hours
continuous parenteral nutrition
continuous administration of parenteral solution over 24 hours
osmolality
continuous administration of parenteral solution over 24 hours
peripheral veins
continuous administration of parenteral solution over 24 hours
central veins
continuous administration of parenteral solution over 24 hours
total nutrient admixture
continuous administration of parenteral solution over 24 hours
720
continuous administration of parenteral solution over 24 hours
cyclic parenteral nutrition
continuous administration of parenteral solution over 24 hours
peripheral parenteral nutrition
continuous administration of parenteral solution over 24 hours
2-in-1 solution
continuous administration of parenteral solution over 24 hours
osmolarity
continuous administration of parenteral solution over 24 hours
refeeding syndrome
continuous administration of parenteral solution over 24 hours
durable power of attorney
continuous administration of parenteral solution over 24 hours
advance directive
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
396
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
578
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
total parenteral nutrition
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
piggyback
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
continuous parenteral nutrition
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
osmolality
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
peripheral veins
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
central veins
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
total nutrient admixture
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
720
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
cyclic parenteral nutrition
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
peripheral parenteral nutrition
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
2-in-1 solution
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
osmolarity
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
refeeding syndrome
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
durable power of attorney
exhibited by severely malnourished patients who are fed aggressively; characterized by fluid and electrolyte imbalances
advance directive
large-diameter veins close to the heart
396
large-diameter veins close to the heart
578
large-diameter veins close to the heart
total parenteral nutrition
large-diameter veins close to the heart
piggyback
large-diameter veins close to the heart
continuous parenteral nutrition
large-diameter veins close to the heart
osmolality
large-diameter veins close to the heart
peripheral veins
large-diameter veins close to the heart
central veins
large-diameter veins close to the heart
total nutrient admixture
large-diameter veins close to the heart
720
large-diameter veins close to the heart
cyclic parenteral nutrition
large-diameter veins close to the heart
peripheral parenteral nutrition
large-diameter veins close to the heart
2-in-1 solution
large-diameter veins close to the heart
osmolarity
large-diameter veins close to the heart
refeeding syndrome
large-diameter veins close to the heart
durable power of attorney
large-diameter veins close to the heart
advance directive
kcalories in 360 mL of a 10% lipid emulsion
396
kcalories in 360 mL of a 10% lipid emulsion
578
kcalories in 360 mL of a 10% lipid emulsion
total parenteral nutrition
kcalories in 360 mL of a 10% lipid emulsion
piggyback
kcalories in 360 mL of a 10% lipid emulsion
continuous parenteral nutrition
kcalories in 360 mL of a 10% lipid emulsion
osmolality
kcalories in 360 mL of a 10% lipid emulsion
peripheral veins
kcalories in 360 mL of a 10% lipid emulsion
central veins
kcalories in 360 mL of a 10% lipid emulsion
total nutrient admixture
kcalories in 360 mL of a 10% lipid emulsion
720
kcalories in 360 mL of a 10% lipid emulsion
cyclic parenteral nutrition
kcalories in 360 mL of a 10% lipid emulsion
peripheral parenteral nutrition
kcalories in 360 mL of a 10% lipid emulsion
2-in-1 solution
kcalories in 360 mL of a 10% lipid emulsion
osmolarity
kcalories in 360 mL of a 10% lipid emulsion
refeeding syndrome
kcalories in 360 mL of a 10% lipid emulsion
durable power of attorney
kcalories in 360 mL of a 10% lipid emulsion
advance directive
parenteral solution that contains dextrose, amino acids, and lipids
396
parenteral solution that contains dextrose, amino acids, and lipids
578
parenteral solution that contains dextrose, amino acids, and lipids
total parenteral nutrition
parenteral solution that contains dextrose, amino acids, and lipids
piggyback
parenteral solution that contains dextrose, amino acids, and lipids
continuous parenteral nutrition
parenteral solution that contains dextrose, amino acids, and lipids
osmolality
parenteral solution that contains dextrose, amino acids, and lipids
peripheral veins
parenteral solution that contains dextrose, amino acids, and lipids
central veins
parenteral solution that contains dextrose, amino acids, and lipids
total nutrient admixture
parenteral solution that contains dextrose, amino acids, and lipids
720
parenteral solution that contains dextrose, amino acids, and lipids
cyclic parenteral nutrition
parenteral solution that contains dextrose, amino acids, and lipids
peripheral parenteral nutrition
parenteral solution that contains dextrose, amino acids, and lipids
2-in-1 solution
parenteral solution that contains dextrose, amino acids, and lipids
osmolarity
parenteral solution that contains dextrose, amino acids, and lipids
refeeding syndrome
parenteral solution that contains dextrose, amino acids, and lipids
durable power of attorney
parenteral solution that contains dextrose, amino acids, and lipids
advance directive
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
396
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
578
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
total parenteral nutrition
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
piggyback
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
continuous parenteral nutrition
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
osmolality
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
peripheral veins
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
central veins
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
total nutrient admixture
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
720
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
cyclic parenteral nutrition
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
peripheral parenteral nutrition
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
2-in-1 solution
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
osmolarity
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
refeeding syndrome
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
durable power of attorney
legal document that gives legal authority to another to make medical decisions in the event of incapacitation
advance directive
type of nutrition support in which the nutrient concentrations do not need to be limited
396
type of nutrition support in which the nutrient concentrations do not need to be limited
578
type of nutrition support in which the nutrient concentrations do not need to be limited
total parenteral nutrition
type of nutrition support in which the nutrient concentrations do not need to be limited
piggyback
type of nutrition support in which the nutrient concentrations do not need to be limited
continuous parenteral nutrition
type of nutrition support in which the nutrient concentrations do not need to be limited
osmolality
type of nutrition support in which the nutrient concentrations do not need to be limited
peripheral veins
type of nutrition support in which the nutrient concentrations do not need to be limited
central veins
type of nutrition support in which the nutrient concentrations do not need to be limited
total nutrient admixture
type of nutrition support in which the nutrient concentrations do not need to be limited
720
type of nutrition support in which the nutrient concentrations do not need to be limited
cyclic parenteral nutrition
type of nutrition support in which the nutrient concentrations do not need to be limited
peripheral parenteral nutrition
type of nutrition support in which the nutrient concentrations do not need to be limited
2-in-1 solution
type of nutrition support in which the nutrient concentrations do not need to be limited
osmolarity
type of nutrition support in which the nutrient concentrations do not need to be limited
refeeding syndrome
type of nutrition support in which the nutrient concentrations do not need to be limited
durable power of attorney
type of nutrition support in which the nutrient concentrations do not need to be limited
advance directive
refers to the concentration of solutes per kilogram of water
396
refers to the concentration of solutes per kilogram of water
578
refers to the concentration of solutes per kilogram of water
total parenteral nutrition
refers to the concentration of solutes per kilogram of water
piggyback
refers to the concentration of solutes per kilogram of water
continuous parenteral nutrition
refers to the concentration of solutes per kilogram of water
osmolality
refers to the concentration of solutes per kilogram of water
peripheral veins
refers to the concentration of solutes per kilogram of water
central veins
refers to the concentration of solutes per kilogram of water
total nutrient admixture
refers to the concentration of solutes per kilogram of water
720
refers to the concentration of solutes per kilogram of water
cyclic parenteral nutrition
refers to the concentration of solutes per kilogram of water
peripheral parenteral nutrition
refers to the concentration of solutes per kilogram of water
2-in-1 solution
refers to the concentration of solutes per kilogram of water
osmolarity
refers to the concentration of solutes per kilogram of water
refeeding syndrome
refers to the concentration of solutes per kilogram of water
durable power of attorney
refers to the concentration of solutes per kilogram of water
advance directive
energy content of 1 L of a parenteral solution that contains 17% dextrose
396
energy content of 1 L of a parenteral solution that contains 17% dextrose
578
energy content of 1 L of a parenteral solution that contains 17% dextrose
total parenteral nutrition
energy content of 1 L of a parenteral solution that contains 17% dextrose
piggyback
energy content of 1 L of a parenteral solution that contains 17% dextrose
continuous parenteral nutrition
energy content of 1 L of a parenteral solution that contains 17% dextrose
osmolality
energy content of 1 L of a parenteral solution that contains 17% dextrose
peripheral veins
energy content of 1 L of a parenteral solution that contains 17% dextrose
central veins
energy content of 1 L of a parenteral solution that contains 17% dextrose
total nutrient admixture
energy content of 1 L of a parenteral solution that contains 17% dextrose
720
energy content of 1 L of a parenteral solution that contains 17% dextrose
cyclic parenteral nutrition
energy content of 1 L of a parenteral solution that contains 17% dextrose
peripheral parenteral nutrition
energy content of 1 L of a parenteral solution that contains 17% dextrose
2-in-1 solution
energy content of 1 L of a parenteral solution that contains 17% dextrose
osmolarity
energy content of 1 L of a parenteral solution that contains 17% dextrose
refeeding syndrome
energy content of 1 L of a parenteral solution that contains 17% dextrose
durable power of attorney
energy content of 1 L of a parenteral solution that contains 17% dextrose
advance directive
administration of a second solution using a separate port in an intravenous catheter
396
administration of a second solution using a separate port in an intravenous catheter
578
administration of a second solution using a separate port in an intravenous catheter
total parenteral nutrition
administration of a second solution using a separate port in an intravenous catheter
piggyback
administration of a second solution using a separate port in an intravenous catheter
continuous parenteral nutrition
administration of a second solution using a separate port in an intravenous catheter
osmolality
administration of a second solution using a separate port in an intravenous catheter
peripheral veins
administration of a second solution using a separate port in an intravenous catheter
central veins
administration of a second solution using a separate port in an intravenous catheter
total nutrient admixture
administration of a second solution using a separate port in an intravenous catheter
720
administration of a second solution using a separate port in an intravenous catheter
cyclic parenteral nutrition
administration of a second solution using a separate port in an intravenous catheter
peripheral parenteral nutrition
administration of a second solution using a separate port in an intravenous catheter
2-in-1 solution
administration of a second solution using a separate port in an intravenous catheter
osmolarity
administration of a second solution using a separate port in an intravenous catheter
refeeding syndrome
administration of a second solution using a separate port in an intravenous catheter
durable power of attorney
administration of a second solution using a separate port in an intravenous catheter
advance directive
administration of a parenteral solution over an 8- to 14-hour period
396
administration of a parenteral solution over an 8- to 14-hour period
578
administration of a parenteral solution over an 8- to 14-hour period
total parenteral nutrition
administration of a parenteral solution over an 8- to 14-hour period
piggyback
administration of a parenteral solution over an 8- to 14-hour period
continuous parenteral nutrition
administration of a parenteral solution over an 8- to 14-hour period
osmolality
administration of a parenteral solution over an 8- to 14-hour period
peripheral veins
administration of a parenteral solution over an 8- to 14-hour period
central veins
administration of a parenteral solution over an 8- to 14-hour period
total nutrient admixture
administration of a parenteral solution over an 8- to 14-hour period
720
administration of a parenteral solution over an 8- to 14-hour period
cyclic parenteral nutrition
administration of a parenteral solution over an 8- to 14-hour period
peripheral parenteral nutrition
administration of a parenteral solution over an 8- to 14-hour period
2-in-1 solution
administration of a parenteral solution over an 8- to 14-hour period
osmolarity
administration of a parenteral solution over an 8- to 14-hour period
refeeding syndrome
administration of a parenteral solution over an 8- to 14-hour period
durable power of attorney
administration of a parenteral solution over an 8- to 14-hour period
advance directive
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
62
Questions 65-68 Short Case Study
Elena Hayes is a 64-year-old realtor. She has been admitted to the local medical center six times in the past 3 months with severe pancreatitis. Elena has been experiencing intractable vomiting and intense pain after eating. Her insurance will not cover home nutritional support. She is being transferred to a subacute nursing facility for therapy.
The registered dietitian completing Elena's initial assessment should expect which result?

A) high albumin
B) weight loss
C) high iron
D) low insulin
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
63
Discuss possible metabolic complications associated with parenteral nutrition and suggest ways to correct such complications.
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
64
The do-not-resuscitate (DNR) order is most often used in patients for whom ____.

A) death is expected and inevitable
B) treatment is excessively costly and not reimbursable
C) organ procurement is in progress
D) families have requested it
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
65
Questions 65-68 Short Case Study
Elena Hayes is a 64-year-old realtor. She has been admitted to the local medical center six times in the past 3 months with severe pancreatitis. Elena has been experiencing intractable vomiting and intense pain after eating. Her insurance will not cover home nutritional support. She is being transferred to a subacute nursing facility for therapy.
Upon admission, Elena tells her nurse that she has a lot of fear with regard to nutrition support because she experienced a "vein blowout" at a previous admission. What is the most likely cause of this incident?

A) high glucose in the TPN
B) low amino acids in the TPN
C) low vitamin K in the PPN
D) high osmolarity of the PPN
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
66
Questions 62-64 Short Case-study  
 
Devon Young is a 30-year-old single male who exercises and follows a healthy diet. His physician admits Devon to the medical-surgical unit for evaluation of reported symptoms of poor appetite, constipation, nausea, and vomiting for 3 days.
After surgery, Devon remains on ventilator support but his gut function is improving. The doctor should initiate ____.

A) a soft diet
B) a clear liquid diet
C) elemental tube feeding
D) PPN
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
67
Define refeeding syndrome. Why does it occur and how can it be prevented?
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
68
Discuss the quality-of-life issues that need to be addressed with patients receiving long-term nutrition support at home.
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
69
Discuss the use of carbohydrates in parenteral nutrition.
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
70
Questions 65-68 Short Case Study
Elena Hayes is a 64-year-old realtor. She has been admitted to the local medical center six times in the past 3 months with severe pancreatitis. Elena has been experiencing intractable vomiting and intense pain after eating. Her insurance will not cover home nutritional support. She is being transferred to a subacute nursing facility for therapy.
Laboratory values indicate that Elena's blood glucose is extremely high. Which nutrient component of her total parenteral nutrition must be adjusted?

A) water
B) dextrose
C) amino acids
D) chromium
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
71
Questions 65-68 Short Case Study
Elena Hayes is a 64-year-old realtor. She has been admitted to the local medical center six times in the past 3 months with severe pancreatitis. Elena has been experiencing intractable vomiting and intense pain after eating. Her insurance will not cover home nutritional support. She is being transferred to a subacute nursing facility for therapy.
The nutrition support team decides to increase the kcal in Ms. Hayes's total parenteral nutrition slowly to prevent ____.

A) hypoglycemia
B) an elevated white blood cell count
C) refeeding syndrome
D) weight gain
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
72
Compare and contrast peripheral parenteral nutrition and total parenteral nutrition.
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
73
Questions 62-64 Short Case-study  
 
Devon Young is a 30-year-old single male who exercises and follows a healthy diet. His physician admits Devon to the medical-surgical unit for evaluation of reported symptoms of poor appetite, constipation, nausea, and vomiting for 3 days.
Upon admission, what diet is most appropriate for Devon until he receives further testing?

A) nothing by mouth
B) low sodium
C) low fiber
D) high protein/high kcalorie
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
74
Questions 62-64 Short Case-study  
 
Devon Young is a 30-year-old single male who exercises and follows a healthy diet. His physician admits Devon to the medical-surgical unit for evaluation of reported symptoms of poor appetite, constipation, nausea, and vomiting for 3 days.
Devon will need intestinal surgery and will be receiving nothing by mouth for 15 to 20 days. How can his medical team meet his nutritional needs during this time?

A) regular diet
B) elemental formula
C) enteral nutrition
D) parenteral nutrition
Unlock Deck
Unlock for access to all 74 flashcards in this deck.
Unlock Deck
k this deck
locked card icon
Unlock Deck
Unlock for access to all 74 flashcards in this deck.